Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt

The hepatitis C virus (HCV) is a major global health challenge and a leading cause of morbidity and mortality. Many direct-acting antivirals (DAAs) target essential macromolecules involved in the virus’ life cycle. Although such DAAs achieve great success in reducing the viral load in genotype 1 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoun, Aly Atef, Abozahra, Rania, Baraka, Kholoud, Mehrez, Mai, Abdelhamid, Sarah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024585/
https://www.ncbi.nlm.nih.gov/pubmed/35456731
http://dx.doi.org/10.3390/microorganisms10040679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024585/
https://www.ncbi.nlm.nih.gov/pubmed/35456731
http://dx.doi.org/10.3390/microorganisms10040679

Ejemplares similares